MedPath

Effect of lanthanum carbonate on serum levels of calcification inhibitor fetuin-A in hemodialysis patients

Not Applicable
Conditions
Chronic kidney disease
Registration Number
JPRN-UMIN000010730
Lead Sponsor
Department of urology, school of medicine,yamaguchi university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Lanthanum carbonate contraindication After parathyroidectomy Peritoneal dialysis patient Digestive tract disease patient Liver dysfunction patient Pregnant woman

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
serum fetuin-A concentration
Secondary Outcome Measures
NameTimeMethod
serum FGF-23 concentration safety evaluation
© Copyright 2025. All Rights Reserved by MedPath